Literature DB >> 22079798

Biocatalytic ketone reduction: a green and efficient access to enantiopure alcohols.

Yan Ni1, Jian-He Xu.   

Abstract

Chiral secondary alcohols play an important role in pharmaceutical, agrochemical, and chemical industries. In recent years, impressive steps forward have been achieved towards biocatalytic ketone reduction as a green and useful access to enantiopure alcohols. An increasing number of novel and robust enzymes are now accessible as a result of the ongoing progress in genomics, screening and evolution technologies, while process engineering provides further success in areas of biocatalytic reduction in meeting synthetic challenges. The versatile platform of these techniques and strategies offers the possibility to apply high substrate loading and thus to overcome the limitation of low volumetric productivity of usual enzymatic processes which is the bottleneck for their practical application. In addition, the integration of bioreduction with other enzymatic or chemical steps allows the efficient synthesis of more complex chiral products.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079798     DOI: 10.1016/j.biotechadv.2011.10.007

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  15 in total

1.  Efficient synthesis of d-phenyllactic acid by a whole-cell biocatalyst co-expressing glucose dehydrogenase and a novel d-lactate dehydrogenase from Lactobacillus rossiae.

Authors:  Xi Luo; Yingying Zhang; Longfei Yin; Weilong Zheng; Yongqian Fu
Journal:  3 Biotech       Date:  2019-12-10       Impact factor: 2.406

2.  Engineering the Cad pathway in Escherichia coli to produce glutarate from L-lysine.

Authors:  Jiaping Wang; Cong Gao; Xiulai Chen; Liming Liu
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-27       Impact factor: 4.813

3.  Insight into the broadened substrate scope of nitrile hydratase by static and dynamic structure analysis.

Authors:  Dong Ma; Zhongyi Cheng; Lukasz Peplowski; Laichuang Han; Yuanyuan Xia; Xiaodong Hou; Junling Guo; Dejing Yin; Yijian Rao; Zhemin Zhou
Journal:  Chem Sci       Date:  2022-07-06       Impact factor: 9.969

4.  Efficient anti-Prelog enantioselective reduction of acetyltrimethylsilane to (R)-1-trimethylsilylethanol by immobilized Candida parapsilosis CCTCC M203011 cells in ionic liquid-based biphasic systems.

Authors:  Bo-Bo Zhang; Jing Cheng; Wen-Yong Lou; Pan Wang; Min-Hua Zong
Journal:  Microb Cell Fact       Date:  2012-08-16       Impact factor: 5.328

5.  Efficient asymmetric reduction of 4-(trimethylsilyl)-3-butyn-2-one by Candida parapsilosis cells in an ionic liquid-containing system.

Authors:  Bo-Bo Zhang; Wen-Yong Lou; Wen-Jing Chen; Min-Hua Zong
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

6.  Whole-cell biotransformation systems for reduction of prochiral carbonyl compounds to chiral alcohol in Escherichia coli.

Authors:  Bingjuan Li; Yuxia Li; Dongmei Bai; Xin Zhang; Huiying Yang; Jie Wang; Gang Liu; Juejie Yue; Yan Ling; Dongsheng Zhou; Huipeng Chen
Journal:  Sci Rep       Date:  2014-10-24       Impact factor: 4.379

7.  Increased availability of NADH in metabolically engineered baker's yeast improves transaminase-oxidoreductase coupled asymmetric whole-cell bioconversion.

Authors:  Jan Dines Knudsen; Cecilia Hägglöf; Nora Weber; Magnus Carlquist
Journal:  Microb Cell Fact       Date:  2016-02-15       Impact factor: 5.328

Review 8.  Recent progress on deep eutectic solvents in biocatalysis.

Authors:  Pei Xu; Gao-Wei Zheng; Min-Hua Zong; Ning Li; Wen-Yong Lou
Journal:  Bioresour Bioprocess       Date:  2017-07-21

9.  A novel carbonyl reductase with anti-Prelog stereospecificity from Acetobacter sp. CCTCC M209061: purification and characterization.

Authors:  Xiao-Hong Chen; Ping Wei; Xiao-Ting Wang; Min-Hua Zong; Wen-Yong Lou
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

10.  Efficient biosynthesis of ethyl (R)-4-chloro-3-hydroxybutyrate using a stereoselective carbonyl reductase from Burkholderia gladioli.

Authors:  Xiang Chen; Zhi-Qiang Liu; Chao-Ping Lin; Yu-Guo Zheng
Journal:  BMC Biotechnol       Date:  2016-10-18       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.